C2N Diagnostics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4340 Duncan Ave, St. Louis, Missouri, 63...Phone Number
(877) 226-3424Website
www.c2n.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About C2N Diagnostics
C2N Diagnostics is a specialty diagnostics company with a vision to bring Clarity Through Innovation. C2N strives to provide exceptional laboratory services and products in the field of brain health. C2N's biomarker services and products are used for: clinical decision making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiologic studies to improve global public health.Explore more
C2N Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is C2N Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
C2N Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at C2N Diagnostics
Product Launch: Get notified when C2N Diagnostics launches new products
Check out if C2N Diagnostics is spiking on competitors!
Earning: See what the market has to say on C2N Diagnostics recently announced quarterly report
Funding: Get notified immidiatlly once C2N Diagnostics has new funding data
Check if C2N Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if C2N Diagnostics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined C2N Diagnostics as Masked Content
Find more new buyers
Compare Similar Companies to C2N Diagnostics
Compare insights from companies similar to C2N Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
C2N Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
C2N Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about C2N Diagnostics.
C2N Diagnostics financials insights
Gather financial insights about C2N Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Grant
$15M
2024
Unspecified
$15M
2025
Other Financing Round
$10M
C2N Diagnostics Tech Stack
A closer look at the technologies used by C2N Diagnostics
Most Recent Scoops
Project
, according to a mid-level source in product development, is in the midst of initiatives related to user experience (UX). The organization is currently evaluating various vendors. C2N Diagnostics will be increasing funding and is expected to increase contingent workforce to support these efforts. The organization is leveraging a third-party company to support development.
Spending/Investment, Product Development, User Experience, Contingent Workforce, Financial Planning, Product Management
Project
, according to a mid-level source in product development, is in the midst of initiatives related to project management software. The organization is currently leveraging Smartsheet.
Product Development, Product Management, Enterprise Software, Software, Workforce Management
Project
, according to a mid-level source in product development, is in the midst of initiatives related to improving time to market. The organization is creating new standard operating procedures (SOPs) and deploying project management solutions to support these efforts.
Implementation, Product Development, Product Launch, Product Management, Workforce Management
Pain Point
, according to a mid-level source in product development, is experiencing challenges related to automated deployment.
Implementation, Pain Point, Product Development, Automation, Product Management, Software
Project
Spending/Investment, Collaboration/Web Apps, Application Development, Product Development, Website, Contingent Workforce, Financial Planning, Product Management
C2N Diagnostics News & Media
Splash Clinical and C2N Diagnostics Partner to Transform Global Clinical Trial Recruitment for Alzheimer's Disease
The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience. The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience.Samsung Invests in C2N Diagnostics
ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a $10 million USD investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corporation (collectively hereinafter referred to as “Samsung”). C2N says Samsung’s decision bolsters its ability to further scale its clinical laboratory services and advanced diagnostic solutions in the fieldC2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
ST. LOUIS--(BUSINESS WIRE)-- #Alzheimers--C2N Diagnostics, LLC (“C2N”), a pioneer in advanced diagnostic testing for brain health, today announced the medical device registration from the United Kingdom’s Medicines and Healthcare products Regulatory Agency (UK MHRA) for the PrecivityAD2™ blood test. The PrecivityAD2 blood test is an analytically and clinically validated multianalyte blood test that determines whether a patient is likely positive or negative for the presence of brain amyloid plaqStudy Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
ST. LOUIS--(BUSINESS WIRE)-- #Alzheimers--Researchers have determined that healthcare providers increased their ability to make Alzheimer’s disease (AD) probability judgments on their patients when they used the PrecivityAD2™ blood biomarker (BBM) tests from C2N Diagnostics, LLC, which aid them in the detection of amyloid plaques in the brain, a pathological hallmark of AD. This change in clinician-reported probability of AD is also associated with meaningful improvements in downstream clinical
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding C2N Diagnostics
Sign Up For FreeTo access detailed company insights
C2N Diagnostics is a specialty diagnostics company with a vision to bring Clarity Through Innovation. C2N strives to provide exceptional laboratory services and products in the field of brain health. C2N's biomarker services and products are used for: clinical decision making to improve patient care, including diagnosis and treatment monitoring; ma... Read More
